Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Dec 10, 2007 at 4:57 PM EST

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the…

Douglas A. McIntyre | Dec 10, 2007 at 11:52 AM EST

Celgene Proves Riskier Than Imagined (CELG)

Celgene Corp. (NASDAQ:CELG) is seeing the price of its shares crushed today after trial results were shown on Sunday at…

Douglas A. McIntyre | Dec 7, 2007 at 12:12 PM EST

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…

Douglas A. McIntyre | Dec 5, 2007 at 12:33 PM EST

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today. All of the talk up…

Douglas A. McIntyre | Dec 5, 2007 at 8:42 AM EST

Lexicon New Alzheimer’s Disease Trial Dosing (LXRX)

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) has announced that dosing has commenced in its Phase IIa clinical trial with LX6171. This…

Douglas A. McIntyre | Dec 4, 2007 at 6:28 PM EST

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…

Douglas A. McIntyre | Dec 4, 2007 at 7:44 AM EST

Medarex Spreads Its Wings (MEDX, BMY)

Medarex, Inc. (Nasdaq: MEDX) this morning has announced the allowance of two separate investigational new drug applications filed with the…

Douglas A. McIntyre | Nov 28, 2007 at 10:18 AM EST

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent…

Douglas A. McIntyre | Nov 21, 2007 at 1:11 PM EST

IPO Filing Floodgates: Bronchus Technologies, Inc. (LUNG)

Bronchus Technologies, Inc. filed yesterday for an initial public offering of up to $86.25 million for filing purposes. It has…

Douglas A. McIntyre | Nov 21, 2007 at 12:55 PM EST

IPO Filing Floodgates: Aegerion Pharmaceuticals, Inc. (AEGR)

Aegerion Pharmaceuticals, Inc. filed Tuesday for an initial public offering of up to $86.25 million in securities for filing purposes. …

Douglas A. McIntyre | Nov 20, 2007 at 3:48 PM EST

Does Big Tobacco Actually Love Pfizer’s Anti-Smoking ‘Chantix’ Pill? (MO, RAI, PFE)

Pfizer (NYSE:PFE) is seeing additional pressure this afternoon. Apparently the FDA said it is looking into reports that Pfizer has…

Douglas A. McIntyre | Nov 20, 2007 at 9:23 AM EST

Quality Systems Free From SEC Inquiry (QSII)

Quality Systems, Inc. (NASDAQ:QSII) has issued a release stating that it received a letter dated November 19, 2007, from the…

Douglas A. McIntyre | Nov 15, 2007 at 3:04 PM EST

GlaxoSmithKline (GSK) Take More Heat

Now that the FDA has forced GlaxoSmithKline (GSK) to put a "black label" on its diabetes drug Avandia, the competition…

Douglas A. McIntyre | Nov 13, 2007 at 4:03 PM EST

Affymetrix Year-Lows On Debt..No Good Deed Goes Unpunished (AFFX)

Affymetrix (NASDAQ:AFFX) was a bit of a puzzling stock today when we saw it had hit a 52-week low after…

Douglas A. McIntyre | Nov 12, 2007 at 1:54 PM EST

Glaxo (GSK) CEO Has A Senior Moment

GlaxoSmithKline’s (GSK) diabetes drug Avandia has such frightening side effects that the FDA will probably make it carry a "black…

1 … 360 361 362 363 364 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Celgene Proves Riskier Than Imagined (CELG)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Lexicon New Alzheimer’s Disease Trial Dosing (LXRX)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Medarex Spreads Its Wings (MEDX, BMY)

Abbott’s (ABT) Hammers Boston Scientific (BSX)

IPO Filing Floodgates: Bronchus Technologies, Inc. (LUNG)

IPO Filing Floodgates: Aegerion Pharmaceuticals, Inc. (AEGR)

Does Big Tobacco Actually Love Pfizer’s Anti-Smoking ‘Chantix’ Pill? (MO, RAI, PFE)

Quality Systems Free From SEC Inquiry (QSII)

GlaxoSmithKline (GSK) Take More Heat

Affymetrix Year-Lows On Debt..No Good Deed Goes Unpunished (AFFX)

Glaxo (GSK) CEO Has A Senior Moment

eBay Slid This Past Month: Why a Leading Analyst Expects 32% Growth Ahead Anyway

AI’s Biggest Opportunity by 2027: NVIDIA vs. Micron

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

eBay Slid This Past Month: Why a Leading Analyst Expects 32% Growth Ahead Anyway

AI’s Biggest Opportunity by 2027: NVIDIA vs. Micron

Health and Healthcare Articles

All Health and Healthcare Articles

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Celgene Proves Riskier Than Imagined (CELG)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Lexicon New Alzheimer’s Disease Trial Dosing (LXRX)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Medarex Spreads Its Wings (MEDX, BMY)

Abbott’s (ABT) Hammers Boston Scientific (BSX)

IPO Filing Floodgates: Bronchus Technologies, Inc. (LUNG)

IPO Filing Floodgates: Aegerion Pharmaceuticals, Inc. (AEGR)

Does Big Tobacco Actually Love Pfizer’s Anti-Smoking ‘Chantix’ Pill? (MO, RAI, PFE)

Quality Systems Free From SEC Inquiry (QSII)

GlaxoSmithKline (GSK) Take More Heat

Affymetrix Year-Lows On Debt..No Good Deed Goes Unpunished (AFFX)

Glaxo (GSK) CEO Has A Senior Moment

eBay Slid This Past Month: Why a Leading Analyst Expects 32% Growth Ahead Anyway

AI’s Biggest Opportunity by 2027: NVIDIA vs. Micron

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Featured Reads

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.